This edition of OIS Retina Innovation Summit has already taken place.
Search future editions →Events › B2B Event
B2B Event
OIS Retina Innovation Summit 2026 is a specialized, one-day conference focusing on innovations in retinal diseases, bridging the gap between emerging technology companies, clinical innovators, and capital investors.
Exhibitor mix: Categorized by presenting companies, sponsors, and investors within retina care.
Planning for next year?
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
Cambridge Healthtech InstituteSubsidiary · Boston, United States · Founded 1992
Produces scientific conferences and publishes research for the pharmaceutical, biotech, and diagnostics industries.
Why people attend
Key industry players attend to discover new technologies, meet emerging companies, and secure strategic partnerships or investment opportunities in retina care.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
239 speakers at OIS Retina Innovation Summit
Head of Translational Medicine · Apellis
Physician scientist (UK trained ophthalmologist) with over 20 years drug discovery and development experience.
Scouting & Transaction Lead in Business Development · Astellas Pharma
Dr. Tomo Oe currently holds the role of Scouting & Transaction Lead in Business Development at Astellas Pharma, where he leads search & evaluation.
Boston Consulting Group
Joe is joining from Boston Consulting Group, where he worked with healthcare and private equity clients on strategy, portfolio planning, and due diligence projects.
Amy Hopkin is an accomplished leader in the pharmaceutical and medical device industries with over a decade of experience in driving innovation and strategic growth.
refractive surgeon
Dr. Daniel Durrie is an internationally recognized refractive surgeon and has performed over 50,000 refractive procedures in his career. He is the founder of Durrie
Strategic business consultant · i2eye Consulting, LLC
Ms. Susan Benton is a strategic business consultant and owner of i2eye Consulting, LLC. Since July 2024, she has been a strategic advisor and consultant.
Hickman Williams & Co.
Also speaking at 2026 Foundry Leadership Summit
Icon Bioscience
Regeneron Laboratories
Also speaking at PODD: Partnership Opportunities in Drug Delivery 2026
Dr. Gebauer has more than 30 years industry experience in research and development and has been part of teams responsible for numerous approvals worldwide.
Google X
Principal Medical Director, US Medical Affairs Ophthalmology · Genentech
Dr. Ivo Stoilov, MD is a Principal Medical Director, US Medical Affairs Ophthalmology, Genentech. He has served as a medical lead for LUCENTIS (ranibizumab injection),…
Versant Ventures
Becton, Dickinson and Company
+ 223 more speakers at this event.
More events in Canada
Frequently asked questions